BMI View: Russia’s healthcare market is in a precarious position due to a severe lack of funding and an
escalating burden of disease. The country’s economic recession will see further pressure placed on the
population for provision of care. Amendments to Russia’s pharmaceutical legislation will, however, favour
domestically-produced medicines over foreign drugmakers and multinational drugmakers will be pressured
to establish a domestic manufacturing presence to comply to related new regulations. Nonetheless, given its
sheer market size and unmet potential, the country will remain attractive for investment by multinational
pharmaceutical firms for long-term growth.
Headline Expenditure Projections
? Pharmaceuticals: RUB1.02trn (USD16.58bn) in 2015 to RUB1.15trn (USD15.42bn) in 2016; +12.7% in
local currency terms and -7.0% in US dollar terms. Forecast unchanged from last quarter.
? Healthcare: RUB5.29trn (USD86.31bn) in 2015 to RUB5.75trn (USD77.30bn) in 2016; +8.6% in local
currency terms and -10.4% in US dollar terms. Forecast unchanged from last quarter.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Russia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020) 28
Industry Risk/Reward Index 29
Central And Eastern Europe Risk/Reward Index 29
Russia Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 40
Pricing Regime 42
Reimbursement Regime 46
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Russia 2010-2015) 49
Table: Healthcare Personnel (Russia 2010-2015) 49
Table: Healthcare Activity (Russia 2010-2015) 50
Research & Development 50
Clinical Trials 51
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 58
Generic Drugmakers 59
Pharmaceutical Retail Sector 60
Company Profile 62
Johnson & Johnson 62
Novartis 65
Pharmstandard 69
Veropharm 73
Demographic Forecast 75
Demographic Outlook 75
Table: Population Headline Indicators (Russia 1990-2025) 76
Table: Key Population Ratios (Russia 1990-2025) 76
Table: Urban/Rural Population & Life Expectancy (Russia 1990-2025) 77
Table: Population By Age Group (Russia 1990-2025) 77
Table: Population By Age Group % (Russia 1990-2025) 78
Glossary 80
Methodology 82
Pharmaceutical Expenditure Forecast Model 82
Healthcare Expenditure Forecast Model 82
Notes On Methodology 83
Risk/Reward Index Methodology 84
Index Overview 85
Table: Pharmaceutical Risk/Reward Index Indicators 85
Indicator Weightings 86

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Russia 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020)
Table: Healthcare Resources (Russia 2010-2015)
Table: Healthcare Personnel (Russia 2010-2015)
Table: Healthcare Activity (Russia 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Russia 1990-2025)
Table: Key Population Ratios (Russia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Russia 1990-2025)
Table: Population By Age Group (Russia 1990-2025)
Table: Population By Age Group % (Russia 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators